Comparison of the clinical effect and side effects of lacosamide with topiramate in controlling migraine headaches

Comparison of the clinical effect and side effects of lacosamide with topiramate in controlling migraine headaches during 3 months

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240930063218N1

Enrollment

Registered

2024-12-19

Start date

2024-10-31

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Migraine

Interventions

Intervention 1: Intervention group: This study is designed as a triple-blind randomized clinical trial. All patients meeting the inclusion criteria will be considered for participation in the study at

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with migraine headache

Exclusion criteria

Exclusion criteria: Under 18 years old Pregnant women Cardiovascular diseases

Design outcomes

Primary

Measure	Time frame
Intensity and frequency of headaches. Timepoint: 3 months. Method of measurement: Visual analogue scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactResearch DepartmentResident

Ghoum University of Medical Sciences

dr.mohammadjavadkhadem@gmail.com+98 25 3612 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026